These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21599022)

  • 1. Bivalent dopamine D2 receptor ligands: synthesis and binding properties.
    Kühhorn J; Hübner H; Gmeiner P
    J Med Chem; 2011 Jul; 54(13):4896-903. PubMed ID: 21599022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a bivalent dopamine D₂ receptor agonist.
    Kühhorn J; Götz A; Hübner H; Thompson D; Whistler J; Gmeiner P
    J Med Chem; 2011 Nov; 54(22):7911-9. PubMed ID: 21999579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and binding profile of haloperidol-based bivalent ligands targeting dopamine D(2)-like receptors.
    Salama I; Löber S; Hübner H; Gmeiner P
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3753-6. PubMed ID: 25047579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homobivalent ligands of the atypical antipsychotic clozapine: design, synthesis, and pharmacological evaluation.
    McRobb FM; Crosby IT; Yuriev E; Lane JR; Capuano B
    J Med Chem; 2012 Feb; 55(4):1622-34. PubMed ID: 22243698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bivalent molecular probes for dopamine D2-like receptors.
    Huber D; Löber S; Hübner H; Gmeiner P
    Bioorg Med Chem; 2012 Jan; 20(1):455-66. PubMed ID: 22100258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of specific probes for human 5-HT4 receptor dimerization studies.
    Soulier JL; Russo O; Giner M; Rivail L; Berthouze M; Ongeri S; Maigret B; Fischmeister R; Lezoualc'h F; Sicsic S; Berque-Bestel I
    J Med Chem; 2005 Oct; 48(20):6220-8. PubMed ID: 16190749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and dopamine D4 receptor binding activities of new N-heteroaromatic 5/6-ring Mannich bases.
    Linz S; Müller J; Hübner H; Gmeiner P; Troschütz R
    Bioorg Med Chem; 2009 Jul; 17(13):4448-58. PubMed ID: 19481941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
    Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH
    J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of privileged structures lead to the discovery of novel biased ligands at the dopamine D₂ receptor.
    Szabo M; Klein Herenbrink C; Christopoulos A; Lane JR; Capuano B
    J Med Chem; 2014 Jun; 57(11):4924-39. PubMed ID: 24827597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-cinnamyl-4-(2-methoxyphenyl)piperazines: synthesis, binding properties, and docking to dopamine (D(2)) and serotonin (5-HT(1A)) receptors.
    Penjisević J; Sukalović V; Andrić D; Kostić-Rajacić S; Soskić V; Roglić G
    Arch Pharm (Weinheim); 2007 Sep; 340(9):456-65. PubMed ID: 17763374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of N-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-2-aryl-2-yl-acetamides and 1-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-3-aryl-2-yl-ureas with dopamine D2 and 5-hydroxytryptamine 5HT(1A) receptors.
    Sukalovic V; Ignjatovic D; Tovilovic G; Andric D; Shakib K; Kostic-Rajacic S; Soskic V
    Bioorg Med Chem Lett; 2012 Jun; 22(12):3967-72. PubMed ID: 22607670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,4-Disubstituted aromatic piperazines with high 5-HT2A/D2 selectivity: Quantitative structure-selectivity investigations, docking, synthesis and biological evaluation.
    Möller D; Salama I; Kling RC; Hübner H; Gmeiner P
    Bioorg Med Chem; 2015 Sep; 23(18):6195-209. PubMed ID: 26299826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,1'-Disubstituted ferrocenes as molecular hinges in mono- and bivalent dopamine receptor ligands.
    Huber D; Hübner H; Gmeiner P
    J Med Chem; 2009 Nov; 52(21):6860-70. PubMed ID: 19807103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of specific bivalent probes that functionally interact with 5-HT(4) receptor dimers.
    Russo O; Berthouze M; Giner M; Soulier JL; Rivail L; Sicsic S; Lezoualc'h F; Jockers R; Berque-Bestel I
    J Med Chem; 2007 Sep; 50(18):4482-92. PubMed ID: 17676726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D2, D3, and D4 selective phenylpiperazines as molecular probes to explore the origins of subtype specific receptor binding.
    Ehrlich K; Götz A; Bollinger S; Tschammer N; Bettinetti L; Härterich S; Hübner H; Lanig H; Gmeiner P
    J Med Chem; 2009 Aug; 52(15):4923-35. PubMed ID: 19606869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-(omega-(4-(2-methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as dopamine D2 and D3 receptor ligands.
    Hackling A; Ghosh R; Perachon S; Mann A; Höltje HD; Wermuth CG; Schwartz JC; Sippl W; Sokoloff P; Stark H
    J Med Chem; 2003 Aug; 46(18):3883-99. PubMed ID: 12930150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenylpiperazinylmethylheterocycle derivatives: synthesis and dopamine receptor binding profiles.
    Abadi AH
    Arch Pharm (Weinheim); 2004 Jul; 337(7):383-90. PubMed ID: 15237388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syntheses and properties of the major hydroxy metabolites in humans of blonanserin AD-5423, a novel antipsychotic agent.
    Ochi T; Sakamoto M; Minamida A; Suzuki K; Ueda T; Une T; Toda H; Matsumoto K; Terauchi Y
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1055-9. PubMed ID: 15686911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Searching for multi-target antipsychotics: Discovery of orally active heterocyclic N-phenylpiperazine ligands of D2-like and 5-HT1A receptors.
    Neves G; Menegatti R; Antonio CB; Grazziottin LR; Vieira RO; Rates SM; Noël F; Barreiro EJ; Fraga CA
    Bioorg Med Chem; 2010 Mar; 18(5):1925-35. PubMed ID: 20153652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid approach for the design of highly affine and selective dopamine D(3) receptor ligands using privileged scaffolds of biogenic amine GPCR ligands.
    Sasse BC; Mach UR; Leppaenen J; Calmels T; Stark H
    Bioorg Med Chem; 2007 Dec; 15(23):7258-73. PubMed ID: 17826096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.